Financials

  • Market Capitalization 88.28 M
  • Employee 76
  • Founded 2018
  • CEO N/A
  • Website www.acrivon.com
  • Headquarter Massachusetts, United States
  • FIGI BBG011RWR2Q4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.19
ratio cours/chiffre d'affaires
464.04

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3982
ICCC
ImmuCell Corporation - Common Stock
9.95 USD-0.70%-1.09%-11.16%+58.19%90.37 M USD
3983
ATRA
Atara Biotherapeutics, Inc. - Common Stock
9.11 USD-1.51%-6.08%+17.70%-38.24%91.44 M USD
3998
RLYB
Rallybio Corporation - Common Stock
16.70 USD-0.36%+0.60%+3.09%+2992.59%88.69 M USD
4002
OKYO
OKYO Pharma Limited - American Depositary Shares
1.63 USD+5.16%+5.84%-4.12%-28.19%85.54 M USD

Nouvelles